Transient Synovitis as a Sequela of COVID-19 Infection: A Case Report and Review of Literature.

J Orthop Case Rep

Department of Orthopaedic Surgery, Naval Medical Center Portsmouth, Portsmouth, Virginia, United States.

Published: February 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Transient synovitis (TS) in the setting of a COVID-19 infection has been reported only a few times in the literature. We report a case of TS 5 weeks following a positive COVID-19 test, in which three modified Kocher criteria were met. We aim to summarize and compare the clinical presentations of prior reported cases, and to expand the current understanding of extrapulmonary manifestations of COVID-19.

Case Report: A 4-year-old female presented with right hip pain and refusal to bear weight on the extremity without a history of trauma. Five weeks prior, the patient tested positive for SARS-Cov-2. The patient met three modified Kocher criteria and an ultrasound of the right hip demonstrated a 6 mm effusion. Synovial fluid analysis and cultures were negative for septic arthritis. The patient was admitted for observation and started on non-steroidal anti-inflammatory drugs with improvement in her pain.

Conclusion: We report a case of TS 5 weeks following COVID-19 infection, and provide a review of the six prior reported cases. Our case differs from prior cases in the timing of hip pain after initial upper respiratory infection symptoms, and the number of modified Kocher criteria met. In the setting of pediatric hip pain, it is important to consider COVID-19 infection as a cause of TS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11823869PMC
http://dx.doi.org/10.13107/jocr.2025.v15.i02.5216DOI Listing

Publication Analysis

Top Keywords

covid-19 infection
16
modified kocher
12
kocher criteria
12
hip pain
12
transient synovitis
8
report case
8
case weeks
8
three modified
8
criteria met
8
prior reported
8

Similar Publications

Background: The COVID-19 pandemic forced the world to quarantine to slow the rate of transmission, causing communities to transition into virtual spaces. Asian American and Pacific Islander communities faced the additional challenge of discrimination that stemmed from racist and xenophobic rhetoric in the media. Limited data exist on technology use among Asian American and Pacific Islander adults during the height of the COVID-19 shelter-in-place period and its effect on their physical and mental health.

View Article and Find Full Text PDF

BackgroundCoronavirus Disease 2019 (COVID-19) has led to dramatic changes including social distancing, closure of schools, travel bans, and issues of stay-at-home orders. The health-care field has been transformed with elective procedures and on-site visits being deferred. Telemedicine has emerged as a novel mechanism to continue to provide care.

View Article and Find Full Text PDF

The COVID-19 pandemic, caused by the continuously evolving SARS-CoV-2 virus, has presented persistent global health challenges. As novel variants emerge, many with enhanced transmissibility and immune evasion capabilities, concerns have intensified regarding the efficacy of existing vaccines and therapeutics. This review provides a comprehensive overview of the current landscape of COVID-19 vaccination, including the development and performance of monovalent and bivalent boosters, and examines their effectiveness against newly emerging variants of interest (VOIs) and variants under monitoring (VUMs), such as JN.

View Article and Find Full Text PDF

The COVID-19 pandemic brought unprecedented global challenges. Amid the crisis, the potential impact of COVID-19 exposure on the neurodevelopment of offspring born to infected mothers emerged as a critical concern. This is a prospective cohort study of pregnant women and their offspring enrolled in the Signature project at Hospital Universitario Virgen del Rocio in Seville, Spain, between 01/01/2024 and 08/31/2022.

View Article and Find Full Text PDF

This article explores two complementary strategies for addressing the affordability and access challenges facing advanced therapies. As high development costs and limited market access have led to the withdrawal of several therapies, the article examines how these barriers create 'valleys of death' that prevent innovation from reaching patients. Through the case of Glybera and other examples, it outlines a rehabilitative approach focused on reforming current systems through improved reimbursement schemes, regulatory streamlining, and more efficient manufacturing.

View Article and Find Full Text PDF